# ViroXis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/viroxis

- Industry: Pharmaceuticals
- Headquarters: San Antonio, US
- Website: www.viroxis.com
- Total disclosed funding: $3.3M
- Latest round: Series A (Jan 18, 2011)
- Investors on record: 2

## About

ViroXis Corp. specializes in premium domain name offerings, providing businesses with valuable digital assets to enhance their online presence and brand visibility across various markets.ViroXis Corp. was founded in 2006 and is headquartered in San Antonio, US. The company focuses on the sale of high-value domain names, facilitating a direct connection for businesses to establish their digital identity. ViroXis was acquired by Quintis (TFS Corporation) in June 2015, although financial terms were not disclosed. The founder’s background is not specified but reflects an entrepreneurial spirit in digital marketing and e-commerce.Viroxis.com offers a premium domain name that serves as an online address for businesses and individuals looking to establish a recognizable digital presence. The core product, a high-value domain, is designed to cater to a variety of end users including entrepreneurs, startups, and established companies seeking to enhance their brand visibility. This domain can function as a critical component for e-commerce platforms, informational websites, or any online service that requires a strong web identity. The primary end use cases include serving as a business's main website or as part of a digital marketing strategy to drive traffic and engagement. The domain is available for purchase globally, appealing to clients across various geographical markets, including North America, Europe, and Asia.Revenue generation for Viroxis.com primarily occurs through the sale of the domain name, priced at USD 5,195, alongside an option for a payment plan of USD 216.46 per month for 24 months. The transaction structure is straightforward, with customers typically engaging in a direct-to-consumer model where they purchase the domain either outright or via installment payments. This approach allows clients the flexibility to acquire the domain name without a substantial upfront investment. The company's revenue streams are complemented by a 30-day satisfaction guarantee, which enhances consumer confidence and facilitates transactions. Overall, the flagship offering remains the domain itself, which is marketed to attract a diverse clientele seeking premium online real estate.As of June 2015, following its acquisition, ViroXis Corp. aims to leverage its resources to expand its portfolio of premium domain names and enhance its marketing strategies. The company is targeting growth in North America, Europe, and Asia, with plans for increased presence in these regions. The recent funding of USD 7.80 mn will be utilized to support the development of new digital marketing tools and enhance customer engagement strategies.

## Funding rounds

- Series A, Jan 18, 2011, $2.5M — Emerging Technology Partners
- Series A, May 26, 2010, $0.8M — Greer Capital

## Investors

- Greer Capital (https://capitalatlas.ai/funds/greer-capital) — Series A
- Emerging Technology Partners (https://capitalatlas.ai/funds/emerging-technology-partners) — Series A